Lobbyist information

Amount

Carol J Holahan	$50,000.00
Employed Terminated 01/01/2023

Kevin C Conroy	$0.00
Employed Terminated 11/06/2023

Martha Coakley	$0.00
Employed Terminated 11/06/2023

Pat A Cerundolo	$120,000.00
Employed Terminated 01/01/2023

Total salaries paid:      $170,000.00

Client information

Amount

American Chemistry Council	$50,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2023 Areas of Interest: All matters associated with chemical and product bans as well as environmental regulations. Names of Legislators/ Regulatory Bodies: TURI and associated boards (Science Advisory Board, Administrative Council), Executive Office of Energy and Environmental Affairs, MassDEP

Amgen Inc.	$0.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2023 Legislation, regulations, and issues related to biopharmaceuticals, health care, drug pricing, transparency, business, and taxation.

GENENTECH, INC.	$0.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2023 Issues, legislation, and administrative actions impacting the biotechnology and pharmaceutical industries, including substitution of interchangeable biosimilars, specialty tier legislation, fail first legislation, house and senate budget

Gilead Sciences, Inc.	$0.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2023 Any and all matters relating to Gilead Sciences, Inc. including HIV/AIDS, Hepatitis C, oncology, drug pricing policy, and patient access to health care.

Massachusetts Biotechnology Council, Inc.

$120,054.64

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2023 Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.

Vertex Pharmaceuticals Incoporated	$0.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2023 All matters related to patient access to medicines, medicaid, drug pricing, and drug cost containment.

Total salaries received:      $170,054.64

Expenditures

Amount